Market News AIOpen the app

Zymeworks will buy back up to $200 million of its own stock by 2028.

PayoutRead the original at SEC EDGAR
Good for ZYME

Zymeworks plans to buy back shares, which could leave each remaining share representing a larger part of the company. The plan can be stopped, and some expected cash depends on a Roche deal and a sales target.

ZYME · Zymeworks Inc.

AI read · Good for ZYME

The AI's read

Buying shares can leave fewer shares outstanding, so each remaining share represents a larger part of the company. The plan can be stopped at any time. Zymeworks also plans to use existing cash, and some expected cash depends on a Roche deal closing and a sales target being met.

Get alerts for ZYME

Follow Zymeworks Inc. (ZYME) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ZYME
Free on the App Store and Google Play, or on the web.